Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study [Phase 2]
This clinical trial update describes a Phase II, multicenter, non-randomized, single-arm study evaluating disitamab vedotin in combination w…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian [Phase 1]
A Phase 1 study investigating AZD2014 (an mTORC1/2 inhibitor) or AZD5363 (an AKT inhibitor) in recurrent endometrial and ovarian cancers, wi…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer [NA]
This ClinicalTrials.gov entry describes a Rutgers-led study focused on enhancing coping and communication for women diagnosed with gynecolog…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
This clinical trial update covers a study of nutritional supplement shakes given to people about to undergo debulking surgery for ovarian ca…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors [Phase 1, Phase 2]
ACE-86225106 is being studied in Phase 1/2 for advanced solid tumors with ongoing recruitment; the study includes BRCA1/BRCA2 mutation-assoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Autophagy Maintenance (AUTOMAIN) [Phase 2]
Phase 2 clinical trial update for Autophagy Maintenance (AUTOMAIN) in ovarian cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss [NA]
ClinicalTrials.gov update for NCT03027479, a study on skeletal muscle energy metabolism in women with weight loss and ovarian and/or endomet…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer [Phase 2]
Phase II trial evaluating weekly paclitaxel/nab-paclitaxel with pembrolizumab and mirabegron for recurrent ovarian cancer is currently recru…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II) [Phase 3]
This Phase 3 clinical trial update notes SENTOV II evaluating the sentinel lymph node technique in early-stage ovarian cancer, which is curr…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) [Phase 2]
This is a Phase 2 clinical trial update for the RESCUE study evaluating secondary cytoreduction using chemotherapy response in recurrent, pl…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) [Phase 1, Phase 2]
This Phase 1/2 study tests durvalumab in combination with chemotherapy as frontline treatment for ovarian cancer and related gynecologic can…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer [Phase 1]
A Phase 1 clinical trial to evaluate the safety and efficacy of OPB-101 in platinum-resistant ovarian cancer is ongoing. The study is curren…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase 3 clinical trial update for HS-20089 injection in platinum-resistant recurrent epithelial ovarian cancer; the study is currently recru…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating QL1706 in combination with chemotherapy and anlotinib for recurrent ovarian cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 1 Study of LNCB74 in Advanced Solid Tumors [Phase 1]
Status update for a Phase 1 study of the investigational agent LNCB74 in patients with various advanced solid tumors, including ovarian, bre…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Feasibility of CALM in Patients With Ovarian Cancer [NA]
The document reports a feasibility trial of CALM in patients with ovarian cancer and indicates that recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study [NA]
This clinical trial aims to overcome immunosuppression and rebalance the immune response in ovarian cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating losartan in combination with paclitaxel for platinum-resistant ovarian cancer; recruitment has not yet sta…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer [Phase 1]
Clinical trial update indicating a Phase 1 study of PIPAC (pressurized intraperitoneal aerosol chemotherapy) to treat peritoneal carcinomato…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating paclitaxel delivered via pressurized intraperitoneal aerosol chemotherapy for platinum-resistant re…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors [NA]
The PONDER trial is studying pelvic peritonectomy for early-stage ovarian tumors with peritoneal carcinomatosis. The study status is NOT_YET…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]
Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer [Phase 1]
Phase 1 study evaluating RP-6306 in combination with carboplatin and paclitaxel for TP53-mutant recurrent ovarian and uterine cancers; the t…